Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
41,342,169
-
Share change
-
+652,468
-
Total reported value
-
$587,744,113
-
Put/Call ratio
-
106%
-
Price per share
-
$14.22
-
Number of holders
-
90
-
Value change
-
-$1,700,738
-
Number of buys
-
52
-
Number of sells
-
33
Institutional Holders of FORMA THERAPEUTICS HLDGS INC - SHS (FMTX) as of Q4 2021
As of 31 Dec 2021,
FORMA THERAPEUTICS HLDGS INC - SHS (FMTX) was held by
90 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,342,169 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., Cormorant Asset Management, LP, FMR LLC, BlackRock Inc., VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, ARMISTICE CAPITAL, LLC, STATE STREET CORP, Logos Global Management LP, and Samsara BioCapital, LLC.
This page lists
90
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.